Carregant...
Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
BACKGROUND: With the recent publication of a large clinical trial on the use of a lower dose of intravenous (IV) tissue plasminogen activator (tPA) for acute ischaemic stroke (AIS), the concept of using a different dose has been debated. We intend to review the literature on using a lower dose of IV...
Guardat en:
| Publicat a: | Stroke Vasc Neurol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5435201/ https://ncbi.nlm.nih.gov/pubmed/28959472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2016-000033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|